Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bio Key International (BKYI) Free Cash Flow (2016 - 2025)

Bio Key International (BKYI) has disclosed Free Cash Flow for 16 consecutive years, with -$1.1 million as the latest value for Q3 2025.

Quarterly Free Cash Flow rose 13.34% to -$1.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$3.4 million through Sep 2025, up 15.3% year-over-year, with the annual reading at -$2.9 million for FY2024, 22.86% up from the prior year.
Free Cash Flow hit -$1.1 million in Q3 2025 for Bio Key International, down from -$881490.0 in the prior quarter.
In the past five years, Free Cash Flow ranged from a high of $295215.0 in Q1 2024 to a low of -$3.2 million in Q1 2021.
Historically, Free Cash Flow has averaged -$1.3 million across 5 years, with a median of -$1.4 million in 2024.
Biggest YoY gain for Free Cash Flow was 115.31% in 2024; the steepest drop was 753.83% in 2024.
Year by year, Free Cash Flow stood at -$1.9 million in 2021, then decreased by 4.12% to -$2.0 million in 2022, then grew by 21.47% to -$1.5 million in 2023, then skyrocketed by 67.08% to -$504564.0 in 2024, then plummeted by 122.78% to -$1.1 million in 2025.
Business Quant data shows Free Cash Flow for BKYI at -$1.1 million in Q3 2025, -$881490.0 in Q2 2025, and -$839882.0 in Q1 2025.